Lonza Group Ag Gross Profit 2012-2023 | LZAGY
- Lonza Group Ag gross profit for the quarter ending December 31, 2023 was $M, a NAN% increase year-over-year.
- Lonza Group Ag gross profit for the twelve months ending December 31, 2023 was $0M, a NAN% increase year-over-year.
- Lonza Group Ag annual gross profit for 2023 was $2.17B, a 15.07% decline from 2022.
- Lonza Group Ag annual gross profit for 2022 was $2.555B, a 10.67% increase from 2021.
- Lonza Group Ag annual gross profit for 2021 was $2.309B, a 17.12% increase from 2020.
Lonza Group Ag Annual Gross Profit (Millions of US $) |
|
---|---|
2023 | $2,170 |
2022 | $2,555 |
2021 | $2,309 |
2020 | $1,971 |
2019 | $2,270 |
2017 | $1,858 |
2016 | $1,422 |
2015 | $1,144 |
2014 | $1,175 |
2013 | $892 |
2012 | $1,072 |
2011 | $793 |
Lonza Group Ag Quarterly Gross Profit (Millions of US $) |
|
---|---|
2023-12-31 | |
2023-06-30 | |
2022-12-31 | |
2022-06-30 | |
2021-12-31 | |
2021-06-30 | |
2020-12-31 | |
2020-06-30 | |
2019-12-31 | |
2019-06-30 | |
2018-12-31 | |
2018-06-30 | |
2017-12-31 | |
2017-06-30 | |
2016-12-31 | |
2016-06-30 | |
2015-12-31 | |
2015-06-30 | |
2014-12-31 | |
2014-06-30 | |
2013-12-31 | |
2013-06-30 | |
2012-12-31 | |
2012-06-30 | |
2011-12-31 | |
2011-06-30 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $40.585B | $7.478B |
Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $180.765B | 23.67 |
Stryker (SYK) | United States | $129.618B | 31.05 |
Boston Scientific (BSX) | United States | $112.981B | 35.99 |
Medtronic (MDT) | Ireland | $100.927B | 15.11 |
EssilorLuxottica (ESLOY) | France | $99.128B | 0.00 |
Haleon (HLN) | United Kingdom | $37.716B | 27.53 |
ResMed (RMD) | United States | $28.121B | 26.40 |
Terumo (TRUMY) | Japan | $24.403B | 34.46 |
Koninklijke Philips (PHG) | Netherlands | $22.841B | 18.13 |
Zimmer Biomet Holdings (ZBH) | United States | $22.328B | 14.26 |
Baxter (BAX) | United States | $17.045B | 12.12 |
Insulet (PODD) | United States | $14.134B | 62.67 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.833B | 0.00 |
Demant (WILYY) | Denmark | $9.370B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.790B | 25.48 |
BellRing Brands (BRBR) | United States | $7.453B | 35.06 |
Lantheus Holdings (LNTH) | United States | $5.565B | 13.87 |
GN Store Nord (GNNDY) | Denmark | $4.222B | 23.71 |
Haemonetics (HAE) | United States | $4.215B | 20.79 |
Perrigo (PRGO) | Ireland | $3.501B | 10.61 |
Prestige Consumer Healthcare (PBH) | United States | $3.437B | 16.35 |
Neogen (NEOG) | United States | $3.386B | 32.56 |
ICU Medical (ICUI) | United States | $2.893B | 25.54 |
Envista Holdings (NVST) | United States | $2.858B | 11.79 |
TG Therapeutics (TGTX) | United States | $2.749B | 77.35 |
Green Thumb Industries (GTBIF) | United States | $2.552B | 49.96 |
Agios Pharmaceuticals (AGIO) | United States | $2.448B | 0.00 |
QuidelOrtho (QDEL) | United States | $2.225B | 12.35 |
LeMaitre Vascular (LMAT) | United States | $1.847B | 54.13 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.804B | 0.00 |
Warby Parker (WRBY) | United States | $1.592B | 0.00 |
InMode (INMD) | Israel | $1.532B | 8.14 |
AdaptHealth (AHCO) | United States | $1.332B | 9.90 |
Verano Holdings (VRNOF) | United States | $1.246B | 0.00 |
AtriCure (ATRC) | United States | $1.084B | 0.00 |
Owens & Minor (OMI) | United States | $1.033B | 9.00 |
National Vision Holdings (EYE) | United States | $1.028B | 32.72 |
BioLife Solutions (BLFS) | United States | $0.987B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.771B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.679B | 14.46 |
Evolus (EOLS) | United States | $0.679B | 0.00 |
PetIQ (PETQ) | United States | $0.656B | 21.21 |
VAREX IMAGING (VREX) | United States | $0.602B | 14.16 |
Surmodics (SRDX) | United States | $0.599B | 37.54 |
Quanterix (QTRX) | United States | $0.506B | 0.00 |
ZimVie (ZIMV) | United States | $0.498B | 42.44 |
Canopy Growth (CGC) | Canada | $0.491B | 0.00 |
Valneva SE (VALN) | France | $0.488B | 0.00 |
Biote (BTMD) | United States | $0.463B | 10.67 |
Jin Medical (ZJYL) | China | $0.403B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.394B | 0.00 |
Cerus (CERS) | United States | $0.325B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.315B | 10.14 |
Zynex (ZYXI) | United States | $0.296B | 40.52 |
MacroGenics (MGNX) | United States | $0.266B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.254B | 25.19 |
Aurora Cannabis (ACB) | Canada | $0.252B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.243B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.236B | 14.85 |
Omeros (OMER) | United States | $0.235B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.233B | 0.00 |
High Tide (HITI) | Canada | $0.178B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.160B | 0.00 |
FitLife Brands (FTLF) | United States | $0.153B | 21.76 |
Capricor Therapeutics (CAPR) | United States | $0.153B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.150B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.137B | 0.00 |
Veru (VERU) | United States | $0.123B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.110B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.104B | 0.00 |
Fonar (FONR) | United States | $0.101B | 10.26 |
Brainsway (BWAY) | Israel | $0.101B | 0.00 |
InterCure (INCR) | Israel | $0.092B | 15.46 |
Cellectar Biosciences (CLRB) | United States | $0.090B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.073B | 4.75 |
MariMed (MRMD) | United States | $0.069B | 0.00 |
Safety Shot (SHOT) | United States | $0.060B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.053B | 0.00 |
Modular Medical (MODD) | United States | $0.051B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.049B | 0.00 |
Bright Green (BGXX) | United States | $0.048B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.048B | 0.00 |
Apyx Medical (APYX) | United States | $0.046B | 0.00 |
United-Guardian (UG) | United States | $0.041B | 14.90 |
Cytosorbents (CTSO) | United States | $0.038B | 0.00 |
ImmuCell (ICCC) | United States | $0.038B | 0.00 |
Exagen (XGN) | United States | $0.032B | 0.00 |
Nephros (NEPH) | United States | $0.022B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.021B | 0.00 |
Agape ATP (ATPC) | $0.016B | 0.00 | |
Trinity Biotech (TRIB) | Ireland | $0.016B | 0.00 |
Flora Growth (FLGC) | United States | $0.013B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
GlucoTrack (GCTK) | United States | $0.011B | 0.00 |
NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |